Published in Immunol Cell Biol on June 25, 2013
Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm (2013) 1.59
Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent. Thyroid (2016) 1.41
Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer Recurrence. PLoS One (2016) 1.40
Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients. J Immunol Res (2014) 1.04
F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner. J Clin Invest (2015) 0.97
Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells. Cancer Immunol Immunother (2014) 0.96
Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities. Front Oncol (2014) 0.94
Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma. Oncoimmunology (2015) 0.89
Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer. J Immunol Res (2014) 0.87
RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. J Clin Invest (2016) 0.85
Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade. Viruses (2016) 0.85
SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells. Cancer Immunol Res (2015) 0.83
Suppression of immune regulatory cells with combined therapy of celecoxib and sunitinib in renal cell carcinoma. Oncotarget (2016) 0.83
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells. Cancer Res (2016) 0.83
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines (Basel) (2016) 0.82
Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Immunosuppressive Microenvironment. Biomed Res Int (2015) 0.81
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma. J Transl Med (2015) 0.81
A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model. Oncotarget (2015) 0.81
Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals. J Virol (2014) 0.80
Role of myeloid-derived suppressor cells in autoimmune disease. World J Immunol (2014) 0.80
Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid. J Cell Biochem (2015) 0.80
Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery. Cancer Gene Ther (2016) 0.80
TRAF3: a novel tumor suppressor gene in macrophages. Macrophage (Houst) (2015) 0.79
HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapy. Mol Med (2015) 0.79
Myeloid-derived suppressor cells in sepsis. Biomed Res Int (2014) 0.79
Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil". Biomedicines (2017) 0.79
Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia. Oncotarget (2015) 0.77
Antigen spreading-induced CD8+T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells. Oncotarget (2015) 0.76
Nano-enabled delivery of diverse payloads across complex biological barriers. J Control Release (2015) 0.76
Tumor cell secretion of soluble factor(s) for specific immunosuppression. Sci Rep (2015) 0.76
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent. Ecancermedicalscience (2016) 0.76
CD13(hi) Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology (2017) 0.75
Detection of inflammatory cell function using (13)C magnetic resonance spectroscopy of hyperpolarized [6-(13)C]-arginine. Sci Rep (2016) 0.75
Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment. Oncotarget (2016) 0.75
Prognostic potential of an immune score based on the density of CD8(+) T cells, CD20(+) B cells, and CD33(+)/p-STAT1(+) double-positive cells and HMGB1 expression within cancer nests in stage IIIA gastric cancer patients. Chin J Cancer Res (2016) 0.75
Immunological Mechanisms of Low and Ultra-Low Dose Cancer Chemotherapy. Cancer Microenviron (2013) 0.75
Monocyte-Derived Dendritic Cells Are Essential for CD8(+) T Cell Activation and Antitumor Responses After Local Immunotherapy. Front Immunol (2015) 0.75
Complement C3 mediated targeting of liposomes to granulocytic myeloid derived suppressor cells. Nanomedicine (2015) 0.75
Inhibiting MDSC differentiation from bone marrow with phytochemical polyacetylenes drastically impairs tumor metastasis. Sci Rep (2016) 0.75
Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy. Clin Immunol (2016) 0.75
Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model. Oncotarget (2015) 0.75
Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function. Front Immunol (2017) 0.75
Dynamics of the spleen and its significance in a murine H22 orthotopic hepatoma model. Exp Biol Med (Maywood) (2016) 0.75
Escape from IFN-γ-dependent immunosurveillance in tumorigenesis. J Biomed Sci (2017) 0.75
Metabolic determinants of the immune modulatory function of neural stem cells. J Neuroinflammation (2016) 0.75
Tropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic Therapy. Sci Rep (2016) 0.75
Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC. Oncotarget (2015) 0.75
Progression of Large Lymphoma Is Significantly Impeded with a Combination of Gemcitabine Chemotherapy and Dendritic Cells Intra-Tumor Vaccination. PLoS One (2015) 0.75
Laparoscopic bile duct exploration via choledochotomy followed by primary duct closure is feasible and safe for the treatment of choledocholithiasis. Surg Endosc (2013) 2.12
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity. Clin Dev Immunol (2012) 1.75
Minimally invasive approaches to the management of pancreatic pseudocysts: review of the literature. Surg Laparosc Endosc Percutan Tech (2003) 1.62
Mild ERCP-induced and non-ERCP-related acute pancreatitis: two distinct clinical entities? J Gastroenterol (2007) 1.46
Admission levels of serum amyloid a and procalcitonin are more predictive of the diagnosis of acute appendicitis compared with C-reactive protein. Surg Laparosc Endosc Percutan Tech (2014) 1.46
Thrombotic microangiopathy in acute pancreatitis. Pancreas (2002) 1.42
Bead-isolated human CD4+CD25+ T regulatory cells are anergic and significantly suppress proliferation of CD4+CD25- T responder cells. Clin Immunol (2006) 1.38
Pregnancy after bariatric surgery does not affect weight loss. BMJ (2012) 1.38
Laparoscopic removal of a huge gastric trichobezoar in a patient with trichotillomania. Surg Laparosc Endosc Percutan Tech (2007) 1.38
Clinical laboratory assessment of acute pancreatitis. Clin Chim Acta (2005) 1.35
Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival. Cancer Immunol Immunother (2007) 1.32
Clinical relevance of intra-abdominal hypertension in patients with severe acute pancreatitis. Pancreas (2008) 1.28
Laparoscopic drainage of pancreatic pseudocysts: a methodological approach. J Gastrointest Surg (2009) 1.20
Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis (2010) 1.20
Laparoscopic versus open distal pancreatectomy: a systematic review of comparative studies. Surg Endosc (2011) 1.15
Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinoma. Clin Cancer Res (2010) 1.14
Urgent versus interval laparoscopic cholecystectomy for acute cholecystitis: a comparative study. J Hepatobiliary Pancreat Surg (2002) 1.08
Neuropilin 1: function and therapeutic potential in cancer. Cancer Immunol Immunother (2013) 1.05
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clin Cancer Res (2008) 1.05
Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg (2003) 1.05
T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspective. Clin Cancer Res (2009) 1.04
Laparoscopic resection of type I choledochal cyst in an adult and Roux-en-Y hepaticojejunostomy: a case report and literature review. Surg Laparosc Endosc Percutan Tech (2006) 1.02
Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells. Clin Immunol (2010) 0.99
Contemporary minimally invasive approaches to the management of acute cholecystitis: a review and appraisal. Surg Laparosc Endosc Percutan Tech (2005) 0.97
Duration of surgery independently influences risk of venous thromboembolism after laparoscopic bariatric surgery. Surg Obes Relat Dis (2011) 0.96
Laparoscopic reduction of an acute gastric volvulus and repair of a hernia of Bochdalek. Surg Laparosc Endosc Percutan Tech (2002) 0.95
The use of a rapid in situ test in the detection of central venous catheter-related bloodstream infection: a prospective study. JPEN J Parenter Enteral Nutr (2003) 0.94
Timing of laparoscopic cholecystectomy for acute cholecystitis: evidence to support a proposal for an early interval surgery. Am Surg (2007) 0.93
Salmonella-mediated tumor regression involves targeting of tumor myeloid suppressor cells causing a shift to M1-like phenotype and reduction in suppressive capacity. Cancer Immunol Immunother (2014) 0.92
Emergency laparoscopic splenectomy for splenic trauma in a Jehovah's Witness patient. Surg Laparosc Endosc Percutan Tech (2008) 0.92
Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer. Expert Opin Biol Ther (2014) 0.92
Laparoscopic versus open splenectomy for massive splenomegaly: a comparative study. J Laparoendosc Adv Surg Tech A (2006) 0.91
Computed tomography to detect accessory spleens before laparoscopic splenectomy: is it necessary? Surg Endosc (2010) 0.89
Laparoscopic gastric bypass for gastric outlet obstruction is associated with smoother, faster recovery and shorter hospital stay compared with open surgery. J Hepatobiliary Pancreat Surg (2005) 0.89
Systematic review of the role of thoracoscopic splanchnicectomy in palliating the pain of patients with chronic pancreatitis. Surg Endosc (2007) 0.88
Transjugular intrahepatic porto-systemic shunt and variceal embolisation in the management of bleeding stomal varices. Int J Colorectal Dis (2005) 0.88
Helios expression in FoxP3(+) T regulatory cells. Expert Opin Biol Ther (2012) 0.87
Laparoscopic enterolithotomy for gallstone ileus. Surg Laparosc Endosc Percutan Tech (2008) 0.87
Gut barrier dysfunction in critically ill surgical patients with abdominal compartment syndrome. Pancreas (2010) 0.87
Laparoscopic lateral pancreaticojejunostomy for chronic pancreatitis: a case report and review of the literature. Surg Laparosc Endosc Percutan Tech (2011) 0.87
An "all 5-mm ports" selective approach to laparoscopic cholecystectomy, appendectomy, and anti-reflux surgery. Surg Laparosc Endosc Percutan Tech (2004) 0.87
Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes. Br J Clin Pharmacol (2012) 0.86
Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma. Cancer Immunol Immunother (2007) 0.85
Laparoscopic diagnosis and management of primary bacterial peritonitis. Surg Laparosc Endosc Percutan Tech (2005) 0.85
Laparoscopic pancreas-preserving total duodenectomy for familial adenomatous polyposis. Surg Laparosc Endosc Percutan Tech (2011) 0.84
Macrophage inhibitory cytokine-1: a review of its pleiotropic actions in cancer. Cancer Biomark (2012) 0.84
A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution. J Pharm Pharmacol (2012) 0.84
Minimally Invasive Distal Pancreatectomy: A Single-Center Analysis of Outcome With Experience and Systematic Review of the Literature. Surg Laparosc Endosc Percutan Tech (2015) 0.84
Laparoscopic endogastric and transgastric cystgastrostomy and pancreatic necrosectomy. Hepatogastroenterology (2008) 0.84
Laparoscopic percutaneous endoscopic gastrostomy removal in a patient with buried-bumper syndrome: a new approach. Surg Laparosc Endosc Percutan Tech (2002) 0.83
Pancreatic surgery in the laparoscopic era. JOP (2003) 0.83
Comment on "Expression of Helios in peripherally induced Foxp3+ regulatory T cells". J Immunol (2012) 0.83
CD8 T-cell recognition of human 5T4 oncofetal antigen. Int J Cancer (2006) 0.83
A Case-matched Comparative Study of Laparoscopic Versus Open Distal Pancreatectomy. Surg Laparosc Endosc Percutan Tech (2015) 0.82
Role of laparoscopic right portal vein ligation in planning staged or major liver resection. J Laparoendosc Adv Surg Tech A (2009) 0.82
Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases. Expert Opin Ther Targets (2014) 0.81
Role of the laparoscopic approach to biliary bypass for benign and malignant biliary diseases: a systematic review. Surg Endosc (2011) 0.81
Closed blunt-trocar 5 mm-port for primary cannulation in laparoscopic surgery: A safe technique. Surg Laparosc Endosc Percutan Tech (2006) 0.80
Extended-release niacin with laropiprant : a review on efficacy, clinical effectiveness and safety. Expert Opin Pharmacother (2012) 0.80
5T4 as a target for immunotherapy in renal cell carcinoma. Expert Rev Anticancer Ther (2009) 0.80
Incidence of perforated gastrojejunal anastomotic ulcers after laparoscopic gastric bypass for morbid obesity and role of laparoscopy in their management. Surg Obes Relat Dis (2011) 0.80
Abdominal wall hernia during laparoscopic gastric bypass: A serious consideration. Obes Surg (2007) 0.78
Factors predictive of frank intrabiliary rupture in patients with hepatic hydatid cysts. Hepatogastroenterology (2007) 0.78
Laparoscopic distal pancreatectomy for a large pancreatic lymphoepithelial cyst: a rare entity. Surg Laparosc Endosc Percutan Tech (2010) 0.78
In vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells. Expert Opin Pharmacother (2014) 0.77
Laparoscopic gastric and biliary bypass: a single-center cohort prospective study. J Laparoendosc Adv Surg Tech A (2006) 0.77
Circulating regulatory T cells in endometrial cancer: a role for age and menopausal status. Immunol Invest (2010) 0.77
Laparoscopic suture repair of selected incisional hernias: a simple technique. J Laparoendosc Adv Surg Tech A (2007) 0.76
Laparoscopic lateral pancreaticojejunostomy and laparoscopic Berne modification of Beger procedure for the treatment of chronic pancreatitis: the first UK experience. Surg Laparosc Endosc Percutan Tech (2014) 0.76
Spontaneous rupture of the splenic capsule with massive bleeding subsequent to the pringle maneuver during laparoscopic liver resection. Surg Laparosc Endosc Percutan Tech (2011) 0.76
The clinical and economic correlates of nonspecific abdominal pain mismanaged by appendectomy. Arch Surg (2003) 0.75
Reply to: doi:10.1007/s00464-013-3395-4: Re: "Laparoscopic bile duct exploration via choledochotomy followed by primary duct closure is feasible and safe…" (2013 (27):4164-4170). Surg Endosc (2014) 0.75
Pancreatic debridement in a district general hospital--viable or vulnerable? Ann R Coll Surg Engl (2004) 0.75
Simultaneous laparoscopic subtotal colectomy and pancreaticoduodenectomy for colonic FAP and ampullary cancer. Surg Laparosc Endosc Percutan Tech (2012) 0.75
Laparoscopic versus open cystgastrostomy for pancreatic pseudocysts: a case-matched comparative study. J Hepatobiliary Pancreat Sci (2014) 0.75
Matched Case-Control Comparative Study of Laparoscopic Versus Open Pancreaticoduodenectomy for Malignant Lesions. Surg Laparosc Endosc Percutan Tech (2017) 0.75
Late perforation at the jejuno-jejunal anastomosis after laparoscopic gastric bypass for morbid obesity. Surg Obes Relat Dis (2013) 0.75
Leukotriene inhibitors in combination with steroids: potential role in the development of primary bacterial peritonitis. Eur J Gastroenterol Hepatol (2005) 0.75
Investigating iron deficiency in the severely obese: challenges and solutions. Br J Hosp Med (Lond) (2012) 0.75
Revision laparoscopic gastric bypass: an effective approach following failure of primary bariatric procedures. Obes Surg (2010) 0.75
Safety and tolerability of extended-release niacin with laropiprant. Expert Opin Drug Saf (2011) 0.75
The safety of laparoscopic hand-sutured gastrojejunostomy in gastric bypass for the treatment of morbid obesity. Obes Surg (2013) 0.75
Laparoscopic surgery for the management of obstruction of the gastric outlet and small bowel following previous laparotomy for major upper gastrointestinal resection or cancer palliation: a new concept. J Laparoendosc Adv Surg Tech A (2005) 0.75
Predictors of duration of postoperative hospital stay in patients undergoing advanced laparoscopic surgery. Surg Laparosc Endosc Percutan Tech (2005) 0.75